SEC Form 4 · accession 0001209191-17-040004
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Blaine Templeman
Officer — Executive VP, General Counsel
Period of report
Jun 12, 2017
Accepted (ET)
Jun 14, 2017 · 9:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.75 | Jun 12, 2017 | A | 27,975 | A | — | Jun 11, 2027 | Common Stock | 27,975 | 27,975 | D |
Explanation of responses
- F1The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of June 12, 2017.